CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sichuan Kelun Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sichuan Kelun Pharmaceutical Co Ltd
No.36
Baihua West Road, Qingyang District
Phone: +86 2882860516p:+86 2882860516 CHENGDU, SIC  610071  China Ticker: 002422002422
Business Summary
SICHUAN KELUN PHARMACEUTICAL CO., LTD. is a China-based company, principally engaged in the research and development, manufacture and distribution of pharmaceutical products. The Company operates its businesses through manufacture and distribution of injections, booster injections, lyophilized power injections, tablets, capsules, granules, oral liquids, dialysis fluids and other form of pharmaceuticals, bulk pharmaceutical chemicals, pharmaceutical packing materials, as well as medical equipment. The Company's injection products include general injections and therapeutic injections, such as glucose injections, sodium chloride injections, glucose and sodium chloride injections, ofloxacin injections, metronidazole injections and norfloxacin injections, among others. Through its subsidiaries, it also engages in the manufacture of rubber and plastic products. The Company distributes its products within domestic market and to overseas markets.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board GexinLiu 72 8/28/2003 1/1/1996
Chief Financial Officer, Deputy General Manager DeguiLai 52 10/23/2014 10/23/2014
General Manager, Director SichuanLiu 39 9/9/2015 6/1/2009
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Klus Pharma, Inc. 9 Deer Park Drive, Suite J-10 Monmouth Junction NJ United States

Business Names
Business Name
002422
Klus Pharma, Inc.
Sichuan Kelun Pharmaceutical Co., Ltd.

General Information
Number of Employees: 19,798 (As of 12/31/2023)
Outstanding Shares: 1,595,551,190 (As of 3/31/2024)
Shareholders: 29,290
Stock Exchange: SHE
Fax Number: +86 2886132515


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024